跳至主要内容
临床试验/NCT03991468
NCT03991468已完成不适用

Clinical Validation for Non-Inferiority of Primary Diagnosis by WSI Hamamatsu NanoZoomer S360MD Digital Slide Scanner System Compared to Conventional Determination by Light Microscope

Hamamatsu Photonics K.K.8 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2019年3月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2,000
试验地点
8
主要终点
Major Discordance Rate

研究概览

简要总结

The primary objective of this study is to evaluate the safety and accuracy of the Hamamatsu WSI compared to those of the reference method (conventional light microscope (Glass)) under clinical use conditions as an aid for pathologists to view, review and diagnose digital images of surgical pathology slides.

The primary endpoint is the indicator of major discordance in primary diagnosis between ground truth case diagnosis and case diagnosis by each modality, WSI and Glass, separately.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Sequential
主要目的
Diagnostic
盲法
Single (Outcomes Assessor)

盲法说明

Adjudicators are blinded to the imaging modality.

入排标准

性别
All
接受健康志愿者

入选标准

  • Cases originating from and that were diagnosed at that local site
  • Cases are available in the site's archive
  • Cases are at least 1 year old since accessioning
  • Cases are selected because their primary diagnosis is consistent with the assigned target categories
  • Cases have a set of slides representative of the primary diagnosis for which it has been selected
  • Slide selection for a given case must meet the following criteria:
  • Slide is obtained by surgical pathology and prepared from FFPE human tissue
  • Slides must be stained with H&E and accompanying special stains (histochemical and/or immunohistochemical)
  • All special stains slides (histochemical and/or immunohistochemical) where the slide and stain is used for diagnosis, not prognosis.
  • A chosen slide must demonstrate and be representative of the primary diagnosis; 1 slide selection may suffice for biopsy cases,
  • For resection cases, a minimum of 5 slides must be selected, which represent the primary diagnosis. If represented with less than 5 slides, additional slides (primary, secondary, or benign slides) from same case may be used to fulfill minimum number
  • Slide is intact, has correct size/thickness, good edges, undamaged coverslip, without pen markings that can't be removed, no air bubbles, tidy labels, and fulfills the quality checks per the general clinical practice

排除标准

  • Case does not have relevant slides or if case information necessary for the study is missing
  • Case is still active (less than 1 year old) at the local site
  • Cases for which the control slides for immunohistochemistry and special stains are not available
  • Two cases from same individual
  • Gross-only cases that have no slides
  • Cases that are frozen section, cytology or hematology or immunofluorescence specimens only
  • Case where the only available set of slides have evidence only of secondary or no diagnoses and not the primary diagnosis for which the case is being screened.
  • Slides for a given case will be excluded if they meet the following criterion:
  • Glass slide that is broken, has abnormal size/thickness, beveled edges, poor coverslip (cracks, waviness, scratches), is sticky, has many pen markings or dirt that cannot be removed, contains air bubbles and overhanging labels that can't be corrected, and if stain is severely faded.

结局指标

主要结局

Major Discordance Rate

时间窗: 1 day

Indpendent reads by four Reading Pathologists (RPs) of both imaging modalitites (8 reads/case) were compared to the original diagnosis ("ground truth" or GT) by an independent adjudication process. This resulted in one of four adjudication outcomes for each read: "Match" (read = GT), "Minor" (minor discordance between read \& GT), "Major" (major discordance between read \& GT), or "Deferred" (read deferred by RP and excluded from the primary endpoint analysis). The outcome measure was the rate at which major discordances occurred for each modality.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验